Showing results (81-90 of 100) with videos related to
Sort By:
Pageof 10
Clinical Therapeutics|March 25, 2019
Efficacy and Tolerability of Telmisartan/Amlodipine and Rosuvastatin Coadministration in Hypertensive Patients with Hyperlipidemia: A Phase III, Multicenter, Randomized, Double-blind StudyTae-Seok Kim, Seung-Woon Rha, Seok-Yeon Kim, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|April 25, 2023
Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertensionKi-Chul Sung, Soon Jun Hong, Moo-Yong Rhee, et al.Clinical Therapeutics|June 3, 2018
Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary HypercholesterolemiaWoohyeun Kim, Yeonyee E Yoon, Sung-Hee Shin, et al.Clinical Therapeutics|April 21, 2018
Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III StudyGyu Chul Oh, Jung-Kyu Han, Ki Hoon Han, et al.Clinical Therapeutics|February 7, 2018
A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled TrialSoon Jun Hong, Han Saem Jeong, Jeong Cheon Ahn, et al.Clinical Therapeutics|September 10, 2021
A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential HypertensionHae-Young Lee, Kwang-Il Kim, Sang Hyun Ihm, et al.Clinical Therapeutics|November 19, 2017
A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and HyperlipidemiaHae-Young Lee, Seok-Yeon Kim, Kee-Joon Choi, et al.Clinical Therapeutics|August 10, 2016
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan MonotherapyKwang-Il Kim, Mi-Seung Shin, Sang-Hyun Ihm, et al.Trials|July 3, 2019
Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): study protocol for a randomized controlled trialMin-Gu Kang, Kwang-Il Kim, Sang Hyun Ihm, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|August 24, 2023
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trialEun Joo Cho, Moo Hyun Kim, Young-Hak Kim, et al.Pageof 10